Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2026-05-22 @ 9:01 PM
Study NCT ID:
NCT00265993
Status:
COMPLETED
Last Update Posted:
2010-02-03
First Post:
2005-12-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Enoxaparin in Acute Venous Thromboembolic Disease
Sponsor:
Sanofi
Organization:
Study Overview
Official Title:
The Efficacy of Subcutaneous Enoxaparin Once Daily in the Treatment of Acute Venous Thromboembolic Disease: an Open-labelled, Non-comparative, Multicentric, Phase IV Trial
Status:
COMPLETED
Status Verified Date:
2010-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study objectives :
* To evaluate the efficacy/safety profile of enoxaparin once a day treatment in acute venous thromboembolic disease.
* To evaluate the efficacy/safety profile of enoxaparin once a day treatment in acute venous thromboembolic disease.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: